{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T07:22:05Z","timestamp":1794468125545,"version":"4.9.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24K18840"],"award-info":[{"award-number":["JP24K18840"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s12149-026-02251-8","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T03:03:00Z","timestamp":1782702180000},"page":"1350-1358","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of biguanide therapy on hepatic 18F-fluorodeoxyglucose-positron emission tomography quantitative parameters in patients with diabetes: a dynamic positron emission tomography study"],"prefix":"10.1007","volume":"40","author":[{"given":"Akiko","family":"Tomiyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9259-6651","authenticated-orcid":false,"given":"Yu","family":"Iwabuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]},{"given":"Kai","family":"Tonda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Owaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arashi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maho","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Togo","family":"Kogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Iwaita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Shiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitake","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Jinzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"2251_CR1","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3390\/ph17040478","volume":"17","author":"G Froldi","year":"2024","unstructured":"Froldi G. View on metformin: antidiabetic and pleiotropic effects, pharmacokinetics, side effects, and sex-related differences. Pharmaceuticals (Basel). 2024;17:478.","journal-title":"Pharmaceuticals (Basel)"},{"key":"2251_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s00259-004-1670-2","volume":"32","author":"M de Groot","year":"2005","unstructured":"de Groot M, Meeuwis AP, Kok PJ, Corstens FH, Oyen WJ. Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut. Eur J Nucl Med Mol Imaging. 2005;32:98\u2013101.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2251_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s43856-025-00755-4","volume":"5","author":"K Sakaguchi","year":"2025","unstructured":"Sakaguchi K, Sugawara K, Hosokawa Y, Ito J, Morita Y, Mizuma H, et al. Metformin-regulated glucose flux from the circulation to the intestinal lumen. Commun Med (Lond). 2025;5:44.","journal-title":"Commun Med (Lond)"},{"key":"2251_CR4","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/dom.14262","volume":"23","author":"J Ito","year":"2021","unstructured":"Ito J, Nogami M, Morita Y, Sakaguchi K, Komada H, Hirota Y, et al. Dose-dependent accumulation of glucose in the intestinal wall and lumen induced by metformin as revealed by 18 F-labelled fluorodeoxyglucose positron emission tomography-MRI. Diabetes Obes Metab. 2021;23:692\u20139.","journal-title":"Diabetes Obes Metab"},{"key":"2251_CR5","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.2337\/dc20-0093","volume":"43","author":"Y Morita","year":"2020","unstructured":"Morita Y, Nogami M, Sakaguchi K, Okada Y, Hirota Y, Sugawara K, et al. Enhanced release of glucose into the intraluminal space of the intestine associated with metformin treatment as revealed by [18F]fluorodeoxyglucose PET-MRI. Diabetes Care. 2020;43:1796\u2013802.","journal-title":"Diabetes Care"},{"key":"2251_CR6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328\u201354.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2251_CR7","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1148\/radiol.2018180078","volume":"289","author":"R Hamidizadeh","year":"2018","unstructured":"Hamidizadeh R, Eftekhari A, Wiley EA, Wilson D, Alden T, B\u00e9nard F. Metformin discontinuation prior to FDG PET\/CT: a randomized controlled study to compare 24- and 48-hour bowel activity. Radiology. 2018;289:418\u201325.","journal-title":"Radiology"},{"key":"2251_CR8","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.2337\/db13-1249","volume":"63","author":"BH Goodpaster","year":"2014","unstructured":"Goodpaster BH, Bertoldo A, Ng JM, Azuma K, Pencek RR, Kelley C, et al. Interactions among glucose delivery, transport, and phosphorylation that underlie skeletal muscle insulin resistance in obesity and type 2 diabetes: studies with dynamic PET imaging. Diabetes. 2014;63:1058\u201368.","journal-title":"Diabetes"},{"key":"2251_CR9","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.jacr.2018.09.006","volume":"16","author":"A Kaiser","year":"2019","unstructured":"Kaiser A, Davenport MS, Frey KA, Greenspan B, Brown RKJ. Management of diabetes mellitus before. J Am Coll Radiol. 2019;16:804\u20139.","journal-title":"J Am Coll Radiol"},{"key":"2251_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/MNM.0b013e32835d1034","volume":"34","author":"F Caobelli","year":"2013","unstructured":"Caobelli F, Pizzocaro C, Paghera B, Guerra UP. Proposal for an optimized protocol for intravenous administration of insulin in diabetic patients undergoing (18)F-FDG PET\/CT. Nucl Med Commun. 2013;34:271\u20135.","journal-title":"Nucl Med Commun"},{"key":"2251_CR11","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.2214\/AJR.10.4663","volume":"195","author":"JR Oh","year":"2010","unstructured":"Oh JR, Song HC, Chong A, Ha JM, Jeong SY, Min JJ, et al. Impact of medication discontinuation on increased intestinal FDG accumulation in diabetic patients treated with metformin. AJR Am J Roentgenol. 2010;195:1404\u201310.","journal-title":"AJR Am J Roentgenol"},{"key":"2251_CR12","doi-asserted-by":"publisher","first-page":"7391","DOI":"10.1088\/0031-9155\/58\/20\/7391","volume":"58","author":"NA Karakatsanis","year":"2013","unstructured":"Karakatsanis NA, Lodge MA, Tahari AK, Zhou Y, Wahl RL, Rahmim A. Dynamic whole-body PET parametric imaging: I. concept, acquisition protocol optimization and clinical application. Phys Med Biol. 2013;58:7391\u2013418.","journal-title":"Phys Med Biol"},{"key":"2251_CR13","doi-asserted-by":"publisher","first-page":"20200810","DOI":"10.1259\/bjr.20200810","volume":"95","author":"X Zhang","year":"2022","unstructured":"Zhang X, Ogihara T, Zhu M, Gantumur D, Li Y, Mizoi K, et al. Effect of metformin on. Br J Radiol. 2022;95:20200810.","journal-title":"Br J Radiol"},{"key":"2251_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00259-007-0563-6","volume":"35","author":"E Gontier","year":"2008","unstructured":"Gontier E, Fourme E, Wartski M, Blondet C, Bonardel G, Le Stanc E, et al. High and typical 18F-FDG bowel uptake in patients treated with metformin. Eur J Nucl Med Mol Imaging. 2008;35:95\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2251_CR15","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.diabres.2017.07.015","volume":"131","author":"JP Koffert","year":"2017","unstructured":"Koffert JP, Mikkola K, Virtanen KA, Andersson AD, Faxius L, H\u00e4llsten K, et al. Metformin treatment significantly enhances intestinal glucose uptake in patients with type 2 diabetes: results from a randomized clinical trial. Diabetes Res Clin Pract. 2017;131:208\u201316.","journal-title":"Diabetes Res Clin Pract"},{"key":"2251_CR16","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00259-009-1330-7","volume":"37","author":"T Oz\u00fclker","year":"2010","unstructured":"Oz\u00fclker T, Oz\u00fclker F, Mert M, Ozpa\u00e7aci T. Clearance of the high intestinal (18)F-FDG uptake associated with metformin after stopping the drug. Eur J Nucl Med Mol Imaging. 2010;37:1011\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2251_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s13340-021-00545-y","volume":"13","author":"H Tsuchida","year":"2022","unstructured":"Tsuchida H, Morita Y, Nogami M, Ogawa W. Metformin action in the gut-insight provided by [18F]FDG PET imaging. Diabetol Int. 2022;13:35\u201340.","journal-title":"Diabetol Int"},{"key":"2251_CR18","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1111\/dom.15247","volume":"25","author":"K Tonda","year":"2023","unstructured":"Tonda K, Iwabuchi Y, Shiga T, Owaki Y, Fujita A, Nakahara T, et al. Impact of patient characteristic factors on the dynamics of liver glucose metabolism: evaluation of multiparametric imaging with dynamic whole-body 18 F-fluorodeoxyglucose-positron emission tomography. Diabetes Obes Metab. 2023;25:3521\u20138.","journal-title":"Diabetes Obes Metab"},{"key":"2251_CR19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40658-022-00490-y","volume":"9","author":"AH Dias","year":"2022","unstructured":"Dias AH, Smith AM, Shah V, Pigg D, Gormsen LC, Munk OL. Clinical validation of a population-based input function for 20-min dynamic whole-body 18F-FDG multiparametric PET imaging. EJNMMI Phys. 2022;9:60.","journal-title":"EJNMMI Phys"},{"key":"2251_CR20","doi-asserted-by":"publisher","first-page":"7419","DOI":"10.1088\/0031-9155\/58\/20\/7419","volume":"58","author":"NA Karakatsanis","year":"2013","unstructured":"Karakatsanis NA, Lodge MA, Zhou Y, Wahl RL, Rahmim A. Dynamic whole-body PET parametric imaging: II Task-oriented statistical estimation. Phys Med Biol. 2013;58:7419\u201345.","journal-title":"Phys Med Biol"},{"key":"2251_CR21","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00259-018-4153-6","volume":"46","author":"A Rahmim","year":"2019","unstructured":"Rahmim A, Lodge MA, Karakatsanis NA, Panin VY, Zhou Y, McMillan A, et al. Dynamic whole-body PET imaging: principles, potentials and applications. Eur J Nucl Med Mol Imaging. 2019;46:501\u201318.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2251_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/jcbfm.1983.1","volume":"3","author":"CS Patlak","year":"1983","unstructured":"Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983;3:1\u20137.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2251_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s40658-020-00330-x","volume":"7","author":"M Naganawa","year":"2020","unstructured":"Naganawa M, Gallezot JD, Shah V, Mulnix T, Young C, Dias M, et al. Assessment of population-based input functions for Patlak imaging of whole body dynamic 18F-FDG PET. EJNMMI Phys. 2020;7:67.","journal-title":"EJNMMI Phys"},{"key":"2251_CR24","doi-asserted-by":"publisher","first-page":"696","DOI":"10.2337\/diacare.13.6.696","volume":"13","author":"A Klip","year":"1990","unstructured":"Klip A, Leiter LA. Cellular mechanism of action of metformin. Diabetes Care. 1990;13:696\u2013704.","journal-title":"Diabetes Care"},{"key":"2251_CR25","first-page":"4059","volume":"81","author":"K Cusi","year":"1996","unstructured":"Cusi K, Consoli A, DeFronzo RA. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1996;81:4059\u201367.","journal-title":"J Clin Endocrinol Metab"},{"key":"2251_CR26","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s12149-020-01509-z","volume":"34","author":"N Schreuder","year":"2020","unstructured":"Schreuder N, Klarenbeek H, Vendel BN, Jager PL, Kosterink JGW, van Puijenbroek EP. Discontinuation of metformin to prevent metformin-induced high colonic FDG uptake: is 48 h sufficient? Ann Nucl Med. 2020;34:833\u20139.","journal-title":"Ann Nucl Med"},{"key":"2251_CR27","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.2337\/diacare.26.7.2069","volume":"26","author":"P Iozzo","year":"2003","unstructured":"Iozzo P, Hallsten K, Oikonen V, Virtanen KA, Parkkola R, Kemppainen J, et al. Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in type 2 diabetes. Diabetes Care. 2003;26:2069\u201374.","journal-title":"Diabetes Care"},{"key":"2251_CR28","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/j.jdiacomp.2016.07.021","volume":"30","author":"K Reynolds","year":"2016","unstructured":"Reynolds K, An J, Wu J, Harrison TN, Wei R, Stuart B, et al. Treatment discontinuation of oral hypoglycemic agents and healthcare utilization among patients with diabetes. J Diabetes Complicat. 2016;30:1443\u201351.","journal-title":"J Diabetes Complicat"},{"key":"2251_CR29","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s12149-014-0840-y","volume":"28","author":"MA Ozguven","year":"2014","unstructured":"Ozguven MA, Karacalioglu AO, Ince S, Emer MO. Altered biodistribution of FDG in patients with type-2 diabetes mellitus. Ann Nucl Med. 2014;28:505\u201311.","journal-title":"Ann Nucl Med"},{"key":"2251_CR30","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1002\/ptr.7387","volume":"36","author":"Z Li","year":"2022","unstructured":"Li Z, Zhang Y, Meng X, Li M, Cao W, Yang J, et al. A novel DPP-4 inhibitor Gramcyclin A attenuates cognitive deficits in APP\/PS1\/tau triple transgenic mice via enhancing brain GLP-1-dependent glucose uptake. Phytother Res. 2022;36:1297\u2013309.","journal-title":"Phytother Res"},{"key":"2251_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2025.102016","volume":"4","author":"BW Sperry","year":"2025","unstructured":"Sperry BW, Almohtasib Y, Ghaly R, Abdel Jawad M, Sauer AJ, Bateman TM. SGLT2 Inhibitor treatment is associated with reduced cardiac glucose metabolism: a matched FDG-PET cohort study. JACC Adv. 2025;4:102016.","journal-title":"JACC Adv"}],"updated-by":[{"DOI":"10.1007\/s12149-026-02311-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:00:00Z","timestamp":1794355200000}}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02251-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-026-02251-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02251-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T06:37:50Z","timestamp":1794465470000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-026-02251-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["2251"],"URL":"https:\/\/doi.org\/10.1007\/s12149-026-02251-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8770927\/v1","asserted-by":"object"}]},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original version of this article, the author name Togo Kogo was incorrectly structured. The correct name is \"Togo Kogo\" and this has been corrected now in the original article.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12149-026-02311-z","URL":"https:\/\/doi.org\/10.1007\/s12149-026-02311-z","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No potential conflicts of interest were disclosed.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}